Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.
about
Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in human lung adenocarcinomas.The Neddylation Inhibitor Pevonedistat (MLN4924) Suppresses and Radiosensitizes Head and Neck Squamous Carcinoma Cells and Tumors.Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle.Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.Regulation of Mammalian DNA Replication via the Ubiquitin-Proteasome System.
P2860
Inactivation of the CRL4-CDT2-SET8/p21 ubiquitylation and degradation axis underlies the therapeutic efficacy of pevonedistat in melanoma.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Inactivation of the CRL4-CDT2- ...... y of pevonedistat in melanoma.
@ast
Inactivation of the CRL4-CDT2- ...... y of pevonedistat in melanoma.
@en
type
label
Inactivation of the CRL4-CDT2- ...... y of pevonedistat in melanoma.
@ast
Inactivation of the CRL4-CDT2- ...... y of pevonedistat in melanoma.
@en
prefLabel
Inactivation of the CRL4-CDT2- ...... y of pevonedistat in melanoma.
@ast
Inactivation of the CRL4-CDT2- ...... y of pevonedistat in melanoma.
@en
P2093
P2860
P1433
P1476
Inactivation of the CRL4-CDT2- ...... y of pevonedistat in melanoma.
@en
P2093
Daniel Gioeli
Fadila Guessous
Joseph Obeid
Kangping Du
Mouadh Benamar
Patrick Corbett
Tarek Abbas
P2860
P304
P356
10.1016/J.EBIOM.2016.06.023
P577
2016-06-16T00:00:00Z